Streptococcus epidermidis ATCC 35984

Information

Microbe Identification

Streptococcus epidermidis ATCC 35984

Microbe id: PMDBM2010041
Level: strain
NCBI Taxonomy ID: n.a.
Taxonomy Species: Streptococcus epidermidis [n.a.]
Taxonomy Genus: Streptococcus [1301]
Taxonomy Family: Streptococcaceae [1300]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Streptococcus epidermidis ATCC 35984

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Streptococcus epidermidis ATCC 35984


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Streptococcus epidermidis ATCC 35984 distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Streptococcus epidermidis ATCC 35984 in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Streptococcus epidermidis ATCC 35984

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗2.413762647298216S
Diabetes Mellitus, Type 2 PRJNA807457🔗-4.2724666192889716S
Liver Cirrhosis, Alcoholic PRJNA690835🔗4.9368065959390816S
Diarrhea PRJNA317326🔗4.5385573529263716S
Colorectal Neoplasms PRJNA824020🔗-4.3832701140926516S
Colorectal Neoplasms PRJEB70916🔗4.16161617236901mNGS
Colorectal Neoplasms PRJDB11845🔗4.3034482793498116S
Colorectal Neoplasms PRJNA1167935🔗4.62799608092443mNGS
Colorectal Neoplasms PRJNA464414🔗4.7085085318419716S
Hepatitis, Autoimmune PRJNA556801🔗4.3117023590375316S
Colitis, Ulcerative PRJNA820056🔗3.0925353030817116S
Colitis, Ulcerative PRJNA993675🔗4.23448742574312mNGS
Campylobacter Infections PRJNA660443🔗3.76869166836266mNGS
Spinal Cord Injuries PRJNA861246🔗2.1621463657914516S
Hepatitis B, Chronic PRJNA872871🔗4.3680486939580216S
Carcinoma, Hepatocellular PRJNA932948🔗4.65884115853384mNGS
Carcinoma, Hepatocellular PRJNA872871🔗4.7828112341780716S
Celiac Disease PRJNA890948🔗4.3189103175945816S
Hepatolenticular Degeneration PRJNA1038771🔗4.1559245457247416S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗4.1912364071325816S
Hidradenitis Suppurativa PRJEB43835🔗4.2381942310143516S
Tic Disorders PRJNA780788🔗4.5396009596360916S
Crohn Disease PRJNA1156939🔗3.8750277225005716S
Crohn Disease PRJNA993675🔗4.4697995172625mNGS
Crohn Disease PRJNA938107🔗4.4945393875492916S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗3.41475521198874mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗4.7871164430537816S
Cholestasis PRJNA478781🔗4.640859363571916S
Moyamoya Disease PRJNA917033🔗3.5791305476794416S
Arthritis, Rheumatoid PRJNA356102🔗-3.1993787216323mNGS
Cholangiocarcinoma PRJNA932948🔗4.62131020694954mNGS
Growth Hormone-Secreting Pituitary Adenoma PRJNA743650🔗-4.9959708298419416S
Anorexia Nervosa PRJEB11199🔗3.2556960647034416S
Neuroblastoma PRJEB63351🔗4.15355777560413mNGS
Graves Ophthalmopathy PRJNA1089481🔗4.6285575700390616S
Irritable Bowel Syndrome PRJEB37924🔗3.93903435924553mNGS
IgA Deficiency PRJNA967340🔗-4.1289773006545416S
Gastroesophageal Reflux PRJNA993632🔗-4.12928922638403mNGS
Diabetes, Gestational PRJNA853814🔗-2.99530958632168mNGS
Diabetes, Gestational PRJNA994318🔗-2.90519184424605mNGS
Infant, Low Birth Weight PRJDB10157🔗-5.3330389831054916S
Glomerulonephritis, IGA PRJNA785415🔗4.8206627113084716S
Liver Cirrhosis PRJNA861246🔗2.2244687199257216S
Liver Cirrhosis PRJNA872871🔗4.1870434326497516S
Cystic Fibrosis PRJNA314903🔗4.59348492508833mNGS
Obesity PRJNA815750🔗-3.4485025375429416S
Obesity PRJNA1125836🔗4.00435796191521mNGS
Diabetes Mellitus PRJNA400325🔗3.8716379450145216S
Diabetes Mellitus PRJNA774037🔗4.7919310784028416S
Autism Spectrum Disorder PRJEB42687🔗3.7219522973535416S
Neuromyelitis Optica PRJNA422961🔗4.3840966089675116S
Inflammatory Bowel Diseases PRJEB13266🔗4.152007784678916S
Hand, Foot and Mouth Disease PRJNA843173🔗4.2680674810331116S
Rhinitis, Allergic PRJNA692671🔗-4.3803523661091116S
Biliary Atresia PRJNA730640🔗4.79894990440892mNGS
Renal Insufficiency, Chronic PRJNA949558🔗4.8841238993676916S
Renal Insufficiency, Chronic PRJNA772031🔗5.3578681177811816S
Breast Neoplasms PRJNA383849🔗3.8235416729015916S
COVID-19 PRJNA678695🔗-4.8017641129512116S
COVID-19 PRJNA907010🔗3.8479906304093916S
COVID-19 PRJNA767939🔗4.1600914134383416S
COVID-19 PRJNA769052🔗4.205329130880916S
COVID-19 PRJDB13214🔗4.2634446389737mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Streptococcus epidermidis ATCC 35984



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Streptococcus epidermidis ATCC 35984



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Streptococcus epidermidis ATCC 35984

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Streptococcus epidermidis ATCC 35984


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Streptococcus epidermidis ATCC 35984



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Streptococcus epidermidis ATCC 35984

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Streptococcus epidermidis ATCC 35984

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Streptococcus epidermidis ATCC 35984

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Streptococcus epidermidis ATCC 35984



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Streptococcus epidermidis ATCC 35984


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Streptococcus epidermidis ATCC 35984


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?